BCLI Live signals | Maximize Profits with Getagraph.com

BUY 139419 min ago

@ $0.370

Issued: 9 Feb 2024 @ 09:30

Return: 30.78%

Previous signal: Feb 8 - 14:29

Previous signal: Sell

Return: -6.68 %

Live Chart Being Loaded With Signals

Commentary (15 May 2024 @ 16:00):

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases...

Stats
Today's Volume	465 241
Average Volume	987 619
Market Cap	33.08M
EPS	$0 ( 2024-04-04 )
Next earnings date	( $-0.0700 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.210
ATR14	$0.00200 (0.40%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-13	Lebovits Chaim	Buy	10 000	Common Stock
2024-05-11	Lebovits Chaim	Buy	10 000	Common Stock
2024-05-10	Lebovits Chaim	Buy	20 000	Common Stock
2024-05-07	Lebovits Chaim	Buy	66 300	Common Stock
2024-05-06	Lebovits Chaim	Buy	135 000	Common Stock

INSIDER POWER
100.00
Last 89 transactions
Buy: 3 035 743 \| Sell: 251 909

Volume Correlation

Long: -0.09 (neutral)

Short: 0.12 (neutral)

Signal:(71.85) Neutral

Brainstorm Cell Correlation

10 Most Positive Correlations
PWFL	0.914
NATR	0.905
APOP	0.893
RAIL	0.892
QADB	0.892
ACTG	0.887
ATOS	0.884
EML	0.884
HEAR	0.883
EFSCP	0.88

10 Most Negative Correlations
RGC	-0.897
TSP	-0.894
ZUMZ	-0.878
RMGC	-0.877
RMRM	-0.876
ORPH	-0.873
RGF	-0.872
ATAK	-0.87
IMRX	-0.869
BTTX	-0.869

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Brainstorm Cell Correlation - Currency/Commodity

-0.02
( neutral )

-0.20
( neutral )

0.00
( neutral )

Brainstorm Cell Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-265 000 (0.00 %)
EPS:	$-0.400

FY	2023
Revenue:	$0
Gross Profit:	$-265 000 (0.00 %)
EPS:	$-0.400

FY	2022
Revenue:	$0
Gross Profit:	$-285 000 (0.00 %)
EPS:	$-0.650

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Brainstorm Cell Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Brainstorm Cell

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and Phase II clinical trial for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other neurodegenerative diseases. The company has a partnership with Catalent for manufacturing NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Realtime updates for Brainstorm Cell [BCLI]

Upcoming Earnings Alert

Brainstorm Cell Options Data

Calls

Puts